RESUMEN
Bariatric surgery is regularly offered to women of childbearing age. Pregnancy after such surgery should be planned and requires special attention. Some complications associated with obesity during pregnancy are reduced after bariatric surgery, but reduced dietary intake and malabsorption can cause nutritional deficiencies, that need to be carefully screened for and supplemented. Dietary management is recommended, and any unusual abdominal pain should be referred to a bariatric surgeon. We offer a summary of recommendations for appropriate follow-up of these pregnancies.
La chirurgie bariatrique est régulièrement proposée à des femmes en âge de procréer. Une grossesse après une telle chirurgie devrait être planifiée et demande une attention particulière. Certaines complications liées à l'obésité durant la grossesse sont réduites après une chirurgie bariatrique mais une diminution des apports alimentaires et la malabsorption peuvent engendrer des carences nutritionnelles qui doivent être attentivement dépistées et supplémentées. Une prise en charge diététique est recommandée et toute douleur abdominale inhabituelle doit faire demander l'avis d'un chirurgien bariatrique. Nous proposons une synthèse des recommandations pour un suivi adéquat de ces grossesses.
Asunto(s)
Cirugía Bariátrica , Desnutrición , Complicaciones del Embarazo , Embarazo , Femenino , Humanos , Cirugía Bariátrica/efectos adversos , Obesidad/complicaciones , Desnutrición/etiología , Periodo Posparto , Suplementos Dietéticos , Complicaciones del Embarazo/etiología , Resultado del EmbarazoRESUMEN
Bariatric and metabolic surgery (BMS) is currently the cornerstone of treatment for severe obesity. It produces significant and lasting weight loss in the vast majority of cases, which depends on the procedure performed, in any case much greater than that observed with non-surgical treatments. This weight loss along with direct metabolic effects of BMS, result in a substantial and lasting improvement in many obesity-related comorbidities, notably metabolic ones, sometimes with complete remission. This leads to a reduction in cardiovascular risk and mortality. Any BMS must be carried out by a multidisciplinary team, which will ensure lifelong follow-up in order to optimize results and prevent complications, including micronutrient deficiencies, by adequate supplementations.
La chirurgie bariatrique et métabolique (CBM) est la pierre angulaire du traitement de l'obésité sévère. Elle permet une perte pondérale conséquente et durable dans la grande majorité des cas, variable selon l'intervention, largement supérieure à celle obtenue de traitements conservateurs. Celle-ci ainsi que les effets métaboliques directs de la CBM s'accompagnent d'améliorations substantielles et durables des comorbidités liées à l'obésité, en particulier métaboliques, voire de rémissions complètes. Ces effets entraînent une réduction du risque cardiovasculaire et de la mortalité. Toute CBM doit être encadrée par une équipe multidisciplinaire, qui s'assurera du suivi à long terme pour optimaliser les résultats et, prévenir les complications, notamment carentielles, par des substitutions adaptées.
Asunto(s)
Cirugía Bariátrica , Obesidad Mórbida , Comorbilidad , Humanos , Obesidad , Obesidad Mórbida/cirugía , Resultado del Tratamiento , Pérdida de PesoRESUMEN
OBJECTIVE: The aim of this paper is to report, with a high follow-up rate, 10-year results in a large cohort of patients after Roux-en-Y gastric bypass (RYGBP) done essentially by laparoscopy. BACKGROUND: RYGBP has been performed for 50 years, including 20 years by laparoscopy, yet very few long-term results have been reported, mostly after open surgery. METHODS: Prospective bariatric database established since the introduction of bariatric surgery. Retrospective data analysis on weight loss, long-term complications, quality of life, and comorbidities. RESULTS: In all, 658 consecutive patients (515 women/143 men) were included: 554 with primary RYGBP, 104 with reoperative RYGBP. There was 1 (0.15%) postoperative death. Thirty-two (5%) patients died during follow-up from causes unrelated to surgery. Ten years after primary RYGBP, patients lost 28.6â±â10.5% of their initial weight, corresponding to a mean of 13.2 body mass index (BMI) units. Among them, 72.8% achieved a BMI <35. Weight loss ≥20% was seen in 80.3% and <10% in 3.9% of patients. Results were similar in patients undergoing primary or reoperative RYGBP, but were better in patients who were initially less obese (BMI <50âkg/m) than in superobese patients. Quality of life and comorbidities significantly improved with 80% resolution or improvement of metabolic comorbidities. All patients required supplementations, and 14.6% required long-term reoperation. CONCLUSIONS: RYGBP provides long-term satisfactory weight loss up to 10 years, and significantly improves quality of life and comorbidities. Long-term complications requiring reoperation can develop. Mineral and vitamin supplementation are universally necessary. Other more effective surgical options should be discussed in patients with very severe obesity.